Post-approval studies (Phase 4)Study completedNCT03376763
What this trial is testing
MAintain the Efficacy and Safety in Treatment of Schizophrenia After Switching to Long-acTing Injectable aRipiprazole From Oral Atypical Antipsychotics
Who this might be right for
SchizophreniaAntipsychoticsLong-Acting Injection+2 more
Korea Otsuka Pharmaceutical Co., Ltd. 201